According to a CBS news report, Biogen’s new Alzheimer’s drug could significantly raise the premium costs for Medicare patients and make the overall program more costly. Aduhelm, a drug administered via infusion to help people with Alzheimer’s, will cost a whopping $56,000 per year for each patient, according to Biogen. […]